Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Large scale newborn deafness genetic screening of 142,417 neonates in Wuhan, China.

Hao Z, Fu D, Ming Y, Yang J, Huang Q, Lin W, Zhang H, Zhang B, Zhou A, Hu X, Yao C, Dong Y, Ring HZ, Ring BZ.

PLoS One. 2018 Apr 10;13(4):e0195740. doi: 10.1371/journal.pone.0195740. eCollection 2018.

2.

Transducin-Like Enhancer of Split 3 (TLE3) Expression Is Associated with Taxane Sensitivity in Nonserous Ovarian Carcinoma in a Three-Cohort Study.

Ring BZ, Murali R, Soslow RA, Bowtell DDL, Fereday S, deFazio A, Traficante N, Kennedy CJ, Brand A, Sharma R, Harnett P, Samimi G; Australian Ovarian Cancer Study.

Cancer Epidemiol Biomarkers Prev. 2018 Jun;27(6):680-688. doi: 10.1158/1055-9965.EPI-17-1101. Epub 2018 Mar 12.

PMID:
29531130
3.

Roles of Rap1 signaling in tumor cell migration and invasion.

Zhang YL, Wang RC, Cheng K, Ring BZ, Su L.

Cancer Biol Med. 2017 Feb;14(1):90-99. doi: 10.20892/j.issn.2095-3941.2016.0086.

4.

Molecular Classification of Lobular Carcinoma of the Breast.

Fu D, Zuo Q, Huang Q, Su L, Ring HZ, Ring BZ.

Sci Rep. 2017 Mar 17;7:43265. doi: 10.1038/srep43265.

5.

p53 alteration in morphologically normal/benign breast tissue in patients with triple-negative high-grade breast carcinomas: breast p53 signature?

Wang X, Stolla M, Ring BZ, Yang Q, Laughlin TS, Rothberg PG, Skinner K, Hicks DG.

Hum Pathol. 2016 Sep;55:196-201. doi: 10.1016/j.humpath.2016.05.011. Epub 2016 May 28.

PMID:
27246177
6.

Erratum to: Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients.

Ring BZ, Hout DR, Morris SW, Lawrence K, Schweitzer BL, Bailey DB, Lehmann BD, Pietenpol JA, Seitz RS.

BMC Cancer. 2016 Apr 18;16:275. doi: 10.1186/s12885-016-2307-0. No abstract available.

7.

Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients.

Ring BZ, Hout DR, Morris SW, Lawrence K, Schweitzer BL, Bailey DB, Lehmann BD, Pietenpol JA, Seitz RS.

BMC Cancer. 2016 Feb 23;16:143. doi: 10.1186/s12885-016-2198-0. Erratum in: BMC Cancer. 2016;16(1):275.

8.

Expression of a-Tocopherol-Associated protein (TAP) is associated with clinical outcome in breast cancer patients.

Wang X, Ring BZ, Seitz RS, Ross DT, Woolf K, Beck RA, Hicks DG, Yeh S.

BMC Clin Pathol. 2015 Dec 9;15:21. doi: 10.1186/s12907-015-0021-5. eCollection 2015.

9.

Analysis of Social and Genetic Factors Influencing Heterosexual Transmission of HIV within Serodiscordant Couples in the Henan Cohort.

Zhu Q, Zhu P, Zhang Y, Li J, Ma X, Li N, Wang Q, Xue X, Luo L, Li Z, Ring HZ, Ring BZ, Su L.

PLoS One. 2015 Jun 11;10(6):e0129979. doi: 10.1371/journal.pone.0129979. eCollection 2015.

10.

Mitochondrial mutations associated with aminoglycoside ototoxicity and hearing loss susceptibility identified by meta-analysis.

Jing W, Zongjie H, Denggang F, Na H, Bin Z, Aifen Z, Xijiang H, Cong Y, Yunping D, Ring HZ, Ring BZ.

J Med Genet. 2015 Feb;52(2):95-103. doi: 10.1136/jmedgenet-2014-102753. Epub 2014 Dec 16.

PMID:
25515069
11.

Ethnic background and genetic variation in the evaluation of cancer risk: a systematic review.

Jing L, Su L, Ring BZ.

PLoS One. 2014 Jun 5;9(6):e97522. doi: 10.1371/journal.pone.0097522. eCollection 2014. Review.

12.

Nuclear SIPA1 activates integrin β1 promoter and promotes invasion of breast cancer cells.

Zhang Y, Gong Y, Hu D, Zhu P, Wang N, Zhang Q, Wang M, Aldeewan A, Xia H, Qu X, Ring BZ, Minato N, Su L.

Oncogene. 2015 Mar 12;34(11):1451-62. doi: 10.1038/onc.2014.36. Epub 2014 Apr 7.

PMID:
24704834
13.

Rapid quantitative detection of Human immunodeficiency virus type 1 by a reverse transcription-loop-mediated isothermal amplification assay.

Zeng Y, Zhang X, Nie K, Ding X, Ring BZ, Xu L, Dai L, Li X, Ren W, Shi L, Ma X.

Gene. 2014 May 15;541(2):123-8. doi: 10.1016/j.gene.2014.03.015. Epub 2014 Mar 12.

PMID:
24630968
14.

Novel EDA p.Ile260Ser mutation linked to non-syndromic hypodontia.

Yang Y, Luo L, Xu J, Zhu P, Xue W, Wang J, Li W, Wang M, Cheng K, Liu S, Tang Z, Ring BZ, Su L.

J Dent Res. 2013 Jun;92(6):500-6. doi: 10.1177/0022034513487557. Epub 2013 Apr 26.

PMID:
23625373
15.

A novel multiplex tetra-primer ARMS-PCR for the simultaneous genotyping of six single nucleotide polymorphisms associated with female cancers.

Zhang C, Liu Y, Ring BZ, Nie K, Yang M, Wang M, Shen H, Wu X, Ma X.

PLoS One. 2013 Apr 17;8(4):e62126. doi: 10.1371/journal.pone.0062126. Print 2013.

16.

ABCB1 variation and treatment response in AIDS patients: initial results of the Henan cohort.

Zhu P, Zhu Q, Zhang Y, Ma X, Li Z, Li J, Chen J, Luo L, Ring HZ, Ring BZ, Su L.

PLoS One. 2013;8(1):e55197. doi: 10.1371/journal.pone.0055197. Epub 2013 Jan 25.

17.

Mammostrat as an immunohistochemical multigene assay for prediction of early relapse risk in the tamoxifen versus exemestane adjuvant multicenter trial pathology study.

Bartlett JM, Bloom KJ, Piper T, Lawton TJ, van de Velde CJ, Ross DT, Ring BZ, Seitz RS, Beck RA, Hasenburg A, Kieback D, Putter H, Markopoulos C, Dirix L, Seynaeve C, Rea D.

J Clin Oncol. 2012 Dec 20;30(36):4477-84. doi: 10.1200/JCO.2012.42.8896. Epub 2012 Oct 8.

PMID:
23045591
18.

TLE3 expression is associated with sensitivity to taxane treatment in ovarian carcinoma.

Samimi G, Ring BZ, Ross DT, Seitz RS, Sutherland RL, O'Brien PM, Hacker NF, Huh WK.

Cancer Epidemiol Biomarkers Prev. 2012 Feb;21(2):273-9. doi: 10.1158/1055-9965.EPI-11-0917. Epub 2011 Dec 22.

19.

Angiosarcoma: a study of 98 cases with immunohistochemical evaluation of TLE3, a recently described marker of potential taxane responsiveness.

Shon W, Jenkins SM, Ross DT, Seitz RS, Beck RA, Ring BZ, Okuno SH, Gibson LE, Folpe AL.

J Cutan Pathol. 2011 Dec;38(12):961-6. doi: 10.1111/j.1600-0560.2011.01790.x.

PMID:
22050093
20.

Putative EPHX1 enzyme activity is related with risk of lung and upper aerodigestive tract cancers: a comprehensive meta-analysis.

Li X, Hu Z, Qu X, Zhu J, Li L, Ring BZ, Su L.

PLoS One. 2011 Mar 18;6(3):e14749. doi: 10.1371/journal.pone.0014749.

21.

Mammostrat as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy.

Bartlett JM, Thomas J, Ross DT, Seitz RS, Ring BZ, Beck RA, Pedersen HC, Munro A, Kunkler IH, Campbell FM, Jack W, Kerr GR, Johnstone L, Cameron DA, Chetty U.

Breast Cancer Res. 2010;12(4):R47. doi: 10.1186/bcr2604. Epub 2010 Jul 8.

22.

The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrence.

Hicks DG, Janarthanan BR, Vardarajan R, Kulkarni SA, Khoury T, Dim D, Budd GT, Yoder BJ, Tubbs R, Schreeder MT, Estopinal NC, Beck RA, Wang Y, Ring BZ, Seitz RS, Ross DT.

BMC Cancer. 2010 Mar 22;10:108. doi: 10.1186/1471-2407-10-108.

23.

Intron 3 16 bp duplication polymorphism of TP53 contributes to cancer susceptibility: a meta-analysis.

Hu Z, Li X, Qu X, He Y, Ring BZ, Song E, Su L.

Carcinogenesis. 2010 Apr;31(4):643-7. doi: 10.1093/carcin/bgq018. Epub 2010 Jan 20.

PMID:
20089604
24.

Three common TP53 polymorphisms in susceptibility to breast cancer, evidence from meta-analysis.

Hu Z, Li X, Yuan R, Ring BZ, Su L.

Breast Cancer Res Treat. 2010 Apr;120(3):705-14. doi: 10.1007/s10549-009-0488-9. Epub 2009 Aug 6.

PMID:
19657731
25.

A novel five-antibody immunohistochemical test for subclassification of lung carcinoma.

Ring BZ, Seitz RS, Beck RA, Shasteen WJ, Soltermann A, Arbogast S, Robert F, Schreeder MT, Ross DT.

Mod Pathol. 2009 Aug;22(8):1032-43. doi: 10.1038/modpathol.2009.60. Epub 2009 May 8.

26.

TLE3 as a candidate biomarker of response to taxane therapy.

Kulkarni SA, Hicks DG, Watroba NL, Murekeyisoni C, Hwang H, Khoury T, Beck RA, Ring BZ, Estopinal NC, Schreeder MT, Seitz RS, Ross DT.

Breast Cancer Res. 2009;11(2):R17. doi: 10.1186/bcr2241. Epub 2009 Mar 23.

27.

Chemosensitivity and stratification by a five monoclonal antibody immunohistochemistry test in the NSABP B14 and B20 trials.

Ross DT, Kim CY, Tang G, Bohn OL, Beck RA, Ring BZ, Seitz RS, Paik S, Costantino JP, Wolmark N.

Clin Cancer Res. 2008 Oct 15;14(20):6602-9. doi: 10.1158/1078-0432.CCR-08-0647.

28.

Gene expression patterns within cell lines are predictive of chemosensitivity.

Ring BZ, Chang S, Ring LW, Seitz RS, Ross DT.

BMC Genomics. 2008 Feb 8;9:74. doi: 10.1186/1471-2164-9-74.

29.

Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer.

Ring BZ, Seitz RS, Beck R, Shasteen WJ, Tarr SM, Cheang MC, Yoder BJ, Budd GT, Nielsen TO, Hicks DG, Estopinal NC, Ross DT.

J Clin Oncol. 2006 Jul 1;24(19):3039-47.

PMID:
16809728
30.

Transcript annotation in FANTOM3: mouse gene catalog based on physical cDNAs.

Maeda N, Kasukawa T, Oyama R, Gough J, Frith M, Engström PG, Lenhard B, Aturaliya RN, Batalov S, Beisel KW, Bult CJ, Fletcher CF, Forrest AR, Furuno M, Hill D, Itoh M, Kanamori-Katayama M, Katayama S, Katoh M, Kawashima T, Quackenbush J, Ravasi T, Ring BZ, Shibata K, Sugiura K, Takenaka Y, Teasdale RD, Wells CA, Zhu Y, Kai C, Kawai J, Hume DA, Carninci P, Hayashizaki Y.

PLoS Genet. 2006 Apr;2(4):e62.

31.

Predicting the sites of metastases.

Ring BZ, Ross DT.

Genome Biol. 2005;6(12):241. Epub 2005 Dec 2. Review.

32.

The transcriptional landscape of the mammalian genome.

Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, Maeda N, Oyama R, Ravasi T, Lenhard B, Wells C, Kodzius R, Shimokawa K, Bajic VB, Brenner SE, Batalov S, Forrest AR, Zavolan M, Davis MJ, Wilming LG, Aidinis V, Allen JE, Ambesi-Impiombato A, Apweiler R, Aturaliya RN, Bailey TL, Bansal M, Baxter L, Beisel KW, Bersano T, Bono H, Chalk AM, Chiu KP, Choudhary V, Christoffels A, Clutterbuck DR, Crowe ML, Dalla E, Dalrymple BP, de Bono B, Della Gatta G, di Bernardo D, Down T, Engstrom P, Fagiolini M, Faulkner G, Fletcher CF, Fukushima T, Furuno M, Futaki S, Gariboldi M, Georgii-Hemming P, Gingeras TR, Gojobori T, Green RE, Gustincich S, Harbers M, Hayashi Y, Hensch TK, Hirokawa N, Hill D, Huminiecki L, Iacono M, Ikeo K, Iwama A, Ishikawa T, Jakt M, Kanapin A, Katoh M, Kawasawa Y, Kelso J, Kitamura H, Kitano H, Kollias G, Krishnan SP, Kruger A, Kummerfeld SK, Kurochkin IV, Lareau LF, Lazarevic D, Lipovich L, Liu J, Liuni S, McWilliam S, Madan Babu M, Madera M, Marchionni L, Matsuda H, Matsuzawa S, Miki H, Mignone F, Miyake S, Morris K, Mottagui-Tabar S, Mulder N, Nakano N, Nakauchi H, Ng P, Nilsson R, Nishiguchi S, Nishikawa S, Nori F, Ohara O, Okazaki Y, Orlando V, Pang KC, Pavan WJ, Pavesi G, Pesole G, Petrovsky N, Piazza S, Reed J, Reid JF, Ring BZ, Ringwald M, Rost B, Ruan Y, Salzberg SL, Sandelin A, Schneider C, Schönbach C, Sekiguchi K, Semple CA, Seno S, Sessa L, Sheng Y, Shibata Y, Shimada H, Shimada K, Silva D, Sinclair B, Sperling S, Stupka E, Sugiura K, Sultana R, Takenaka Y, Taki K, Tammoja K, Tan SL, Tang S, Taylor MS, Tegner J, Teichmann SA, Ueda HR, van Nimwegen E, Verardo R, Wei CL, Yagi K, Yamanishi H, Zabarovsky E, Zhu S, Zimmer A, Hide W, Bult C, Grimmond SM, Teasdale RD, Liu ET, Brusic V, Quackenbush J, Wahlestedt C, Mattick JS, Hume DA, Kai C, Sasaki D, Tomaru Y, Fukuda S, Kanamori-Katayama M, Suzuki M, Aoki J, Arakawa T, Iida J, Imamura K, Itoh M, Kato T, Kawaji H, Kawagashira N, Kawashima T, Kojima M, Kondo S, Konno H, Nakano K, Ninomiya N, Nishio T, Okada M, Plessy C, Shibata K, Shiraki T, Suzuki S, Tagami M, Waki K, Watahiki A, Okamura-Oho Y, Suzuki H, Kawai J, Hayashizaki Y; FANTOM Consortium; RIKEN Genome Exploration Research Group and Genome Science Group (Genome Network Project Core Group).

Science. 2005 Sep 2;309(5740):1559-63. Erratum in: Science. 2006 Mar 24;311(5768):1713.

33.

Human disease genes and their cloned mouse orthologs: exploration of the FANTOM2 cDNA sequence data set.

Schriml LM, Hill DP, Blake JA, Bono H, Wynshaw-Boris A, Pavan WJ, Ring BZ, Beisel K, Setou M, Okazaki Y; RIKEN GER Group; GSL Members.

Genome Res. 2003 Jun;13(6B):1496-500.

34.

Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs.

Okazaki Y, Furuno M, Kasukawa T, Adachi J, Bono H, Kondo S, Nikaido I, Osato N, Saito R, Suzuki H, Yamanaka I, Kiyosawa H, Yagi K, Tomaru Y, Hasegawa Y, Nogami A, Schönbach C, Gojobori T, Baldarelli R, Hill DP, Bult C, Hume DA, Quackenbush J, Schriml LM, Kanapin A, Matsuda H, Batalov S, Beisel KW, Blake JA, Bradt D, Brusic V, Chothia C, Corbani LE, Cousins S, Dalla E, Dragani TA, Fletcher CF, Forrest A, Frazer KS, Gaasterland T, Gariboldi M, Gissi C, Godzik A, Gough J, Grimmond S, Gustincich S, Hirokawa N, Jackson IJ, Jarvis ED, Kanai A, Kawaji H, Kawasawa Y, Kedzierski RM, King BL, Konagaya A, Kurochkin IV, Lee Y, Lenhard B, Lyons PA, Maglott DR, Maltais L, Marchionni L, McKenzie L, Miki H, Nagashima T, Numata K, Okido T, Pavan WJ, Pertea G, Pesole G, Petrovsky N, Pillai R, Pontius JU, Qi D, Ramachandran S, Ravasi T, Reed JC, Reed DJ, Reid J, Ring BZ, Ringwald M, Sandelin A, Schneider C, Semple CA, Setou M, Shimada K, Sultana R, Takenaka Y, Taylor MS, Teasdale RD, Tomita M, Verardo R, Wagner L, Wahlestedt C, Wang Y, Watanabe Y, Wells C, Wilming LG, Wynshaw-Boris A, Yanagisawa M, Yang I, Yang L, Yuan Z, Zavolan M, Zhu Y, Zimmer A, Carninci P, Hayatsu N, Hirozane-Kishikawa T, Konno H, Nakamura M, Sakazume N, Sato K, Shiraki T, Waki K, Kawai J, Aizawa K, Arakawa T, Fukuda S, Hara A, Hashizume W, Imotani K, Ishii Y, Itoh M, Kagawa I, Miyazaki A, Sakai K, Sasaki D, Shibata K, Shinagawa A, Yasunishi A, Yoshino M, Waterston R, Lander ES, Rogers J, Birney E, Hayashizaki Y; FANTOM Consortium; RIKEN Genome Exploration Research Group Phase I & II Team.

Nature. 2002 Dec 5;420(6915):563-73.

PMID:
12466851
35.

Microarrays and molecular markers for tumor classification.

Ring BZ, Ross DT.

Genome Biol. 2002;3(5):comment2005. Epub 2002 Apr 29. Review.

36.

Regulation of mouse lens fiber cell development and differentiation by the Maf gene.

Ring BZ, Cordes SP, Overbeek PA, Barsh GS.

Development. 2000 Jan;127(2):307-17.

37.

Function of E. coli RNA polymerase sigma factor sigma 70 in promoter-proximal pausing.

Ring BZ, Yarnell WS, Roberts JW.

Cell. 1996 Aug 9;86(3):485-93.

38.

Function of a nontranscribed DNA strand site in transcription elongation.

Ring BZ, Roberts JW.

Cell. 1994 Jul 29;78(2):317-24.

PMID:
8044843

Supplemental Content

Support Center